GlaxoSmithKline isn’t the only one hiring, others are hiring too! Check it out! (Isn’t it tempting?)
Amid the recent swirl of pharmaceutical company takeovers and trades, GlaxoSmithKline chief executive officer Andrew Witty said Wednesday that GSK might end up with more Philadelphia-area employees if a deal with Novartis is completed. Witty said the business units joining GSK have about 10,000 people and the units going to Novartis have about 2,000 people. “On day one, there is a significant net influx of people to GSK, and therefore in most of our geographies - and the Delaware Valley, I suspect, will be no exception - there might be net benefit,” Witty said during a conference call with reporters after the company released first-quarter financial results.
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
